IndexIQ Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
NAMA
IndexIQ Advisors's EXAS Position: Q1 2022 in Review
IndexIQ Advisors increased its Exact Sciences (EXAS) stake by 15% in Q1 2022, buying an estimated $32K and bringing the position to 3,298 shares worth $230K. The position accounts for 0.01% of the portfolio, ranked #1016.
IndexIQ Advisors first reported a position in EXAS in Q2 2021 and has held it in 4 quarters since. The position peaked at $344K in Q2 2021. 558 funds tracked by Wall St. Rank hold EXAS as of Q1 2022.
- IndexIQ Advisors held 3,298 shares of Exact Sciences worth $230K as of Q1 2022.
- IndexIQ Advisors bought 438 Exact Sciences shares in Q1 2022, an estimated $32K.
- Exact Sciences made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #1016 holding.
- IndexIQ Advisors first reported a position in Exact Sciences in Q2 2021 and has held it in 4 quarters since.
- IndexIQ Advisors's Exact Sciences position peaked at $344K in Q2 2021.
- 558 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2022.
Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.